Methyl 4-(hydroxymethyl)piperidine-1-carboxylate, 97.0%, 500mg

2-Methyl-4-phenylthiazole>98.0%(GC)5g

(R)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 25g

5-Amino-3-(2-furyl)pyrazole, 97.0%, 25g

4-Bromo-1-isopropyl-2-nitrobenzene, 98%, 500mg

(S)-(2-Amino-5-methoxy-4-((triisopropylsilyl)oxy)phenyl)(6-(((tert-butyldimethylsilyl)oxy)methyl)-5-azaspiro[2.4]heptan-5-yl)methanone, 100mg

Gallic acid monohydrate, min. 99%, 50 g, plastic packaging.

2,6-BIS[(4S)-4,5-DIHYDRO-4-(1-METHYLETHYL)-5,5-DIPHENYL-2-OXAZOLYL]PYRIDINE, 95%, 250mg

4-Chloro-2,6-dimethylpyrimidine, 97.0%, 10g

Benzyl 4-oxo-2-(trifluoromethyl)piperidine-1-carboxylate, 95.0%, 250mg

4-((2-Nitrophenyl)amino)phenol, 98% GC, 250mg

1-Cyclopropyl-1H-pyrazole, 95.0%, 1g

4-(4-Chlorobenzenesulfonyl)benzaldehyde, 95.0%, 1g